4.7 Review

Role of chemokines in T-cell acute lymphoblastic Leukemia: From pathogenesis to therapeutic options

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Hematology

Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma

Keisuke Watanabe et al.

Summary: A challenge in targeting T-cell lymphoma with CAR-T therapy is fratricide between CAR-T cells and normal T cells due to shared target antigens. CCR4 is highly expressed in T-cell malignancies and has unique expression in normal T cells. This study demonstrates that anti-CCR4 CAR-T cells can selectively deplete Th2 and Treg cells while sparing CD8+ and Th1 T cells.

BLOOD ADVANCES (2023)

Article Hematology

Epigenetic changes in human model KMT2A leukemias highlight early events during leukemogenesis

Thomas Milan et al.

Summary: Chromosomal translocations involving the KMT2A gene are common in pediatric acute myeloid leukemias. This study investigated the molecular mechanisms of the disease using a human model system. It found that changes in DNA methylation, histone modifications, and chromatin accessibility, as well as expression changes, are associated with leukemic transformation. The study also identified a potential essential gene and signaling pathway involved in leukemogenesis.

HAEMATOLOGICA (2022)

Article Biochemistry & Molecular Biology

Fast H3K9 methylation promoted by CXCL12 contributes to nuclear changes and invasiveness of T-acute lymphoblastic leukemia cells

Elena Madrazo et al.

Summary: CXCL12 has novel regulatory functions in nuclear deformability and epigenetic changes of T-ALL cells, making it a potential pharmacological target for treating T-ALL dissemination.

ONCOGENE (2022)

Review Oncology

Chemokine Receptor-Targeted Therapies: Special Case for CCR8

Bernhard Moser

Summary: Antibodies targeting immune checkpoint molecules have improved cancer therapy. CCR8, a chemokine receptor highly expressed on suppressive immune cells, is a potential target in cancer therapy.

CANCERS (2022)

Review Cell Biology

C-C Chemokine Receptor 7 in Cancer

Colin A. Bill et al.

Summary: CCR7 plays distinct roles in different cancers, promoting migration of malignant cells to lymph nodes in some cases and even serving a protective role in certain tumors. Future studies should focus on defining mechanisms that regulate the unfavorable or beneficial effects of CCR7 in cancer pathophysiology, in order to improve outcomes in patients with CCR7-positive cancers.
Article Hematology

Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia

Paul M. Maciocia et al.

Summary: CCR9 expression is found in the majority of T-ALL cases, making it a potential target for CAR-T cell therapy. CAR-T cells targeting CCR9 can effectively inhibit leukemia cell proliferation without harming healthy T cells, providing a promising treatment strategy for T-ALL.
Article Oncology

CXCR4 mediates leukemic cell migration and survival in the testicular microenvironment

Tessa Skroblyn et al.

Summary: The study identified CXCL12-CXCR4 as the leading signaling axis for B-ALL cell migration and survival in the testicular leukemic niche. CXCR4 was found to be the only chemokine receptor robustly expressed on B-ALL cells in both diagnosis and relapse samples. Blocking CXCR4 functions showed promising results in preventing testicular infiltration and overall development of leukemia.

JOURNAL OF PATHOLOGY (2022)

Review Oncology

Chimeric Antigen Receptor Based Cellular Therapy for Treatment Of T-Cell Malignancies

Kamila Polgarova et al.

Summary: T-cell malignancies can be divided into precursor and mature types, with aggressive behavior and poor prognosis. Targeted therapies are only effective in subsets of patients. CAR-T cell therapy shows potential for T-cell malignancies, but specific obstacles need to be addressed. Further research is needed to optimize CAR-based products and evaluate long-term outcomes.

FRONTIERS IN ONCOLOGY (2022)

Article Immunology

Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9+ tumors

Silvia Santamaria et al.

Summary: Relapsed or refractory T-acute lymphoblastic leukemia (T-ALL) has a poor prognosis. An anti-CCR9 monoclonal antibody (mAb 92R) has been found to inhibit tumor growth and increase survival in T-ALL, and in combination with chemotherapy, it shows even better therapeutic effects. Furthermore, a humanized version of the antibody (Srb1) also has the potential to inhibit tumor growth.

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

Growth arrest-specific protein 2 (GAS2) interacts with CXCR4 to promote T-cell leukemogenesis partially via c-MYC

Wenjuan Ma et al.

Summary: This study reveals that GAS2 promotes T-cell leukemogenesis through its interaction with CXCR4 to activate NOTCH1/c-MYC pathway. Loss of GAS2 has a mild effect on normal hematopoiesis.

MOLECULAR ONCOLOGY (2022)

Article Medicine, Research & Experimental

Endothelial PERK-ATF4-JAG1 axis activated by T-ALL remodels bone marrow vascular niche

Cui Liu et al.

Summary: The endoplasmic reticulum unfolded protein response (UPR) is activated during T-cell acute lymphoblastic leukemia (T-ALL) development, leading to remodeling of the bone marrow vascular niche. Targeting endothelial PERK improves T-ALL treatment outcomes and affects hematopoietic stem cell maintenance and leukemia apoptosis.

THERANOSTICS (2022)

Review Cell Biology

At the bedside: Profiling and treating patients with CXCR4-expressing cancers

Miguel Martin et al.

Summary: CXCR4 and CXCL12 play crucial roles in tumor development, with CXCR4 being a potential therapeutic target. While the only marketed CXCR4 inhibitor currently is plerixafor, several new inhibitors are under investigation. Early clinical evidence shows these inhibitors to be effective and well tolerated.

JOURNAL OF LEUKOCYTE BIOLOGY (2021)

Article Immunology

Posttransplant blockade of CXCR4 improves leukemia complete remission rates and donor stem cell engraftment without aggravating GVHD

Long Su et al.

Summary: The study showed that posttransplant treatment with the CXCR4 antagonist AMD3100 significantly improved the eradication of leukemia cells in the BM, enhanced GVL effects, and promoted donor hematopoietic engraftment. Additionally, posttransplant treatment with AMD3100 had no detectable deleterious effect related to GVHD.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

LINC00853 restrains T cell acute lymphoblastic leukemia invasion and infiltration by regulating CCR9/CCL25

Jingyuan Li et al.

Summary: This study identified a negative correlation between LINC00853 and CCR9 expression in T-ALL, with LINC00853 suppressing cell migration and invasion by regulating the CCR9/CCL25 pathway.

MOLECULAR IMMUNOLOGY (2021)

Article Oncology

Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy

Helena Van Damme et al.

Summary: Regulatory T cells (Tregs) play a role in antitumor immunotherapy, but lack of selectivity for tumor-infiltrating Tregs can lead to adverse effects. CCR8-specific nanobodies were developed to selectively deplete tumor-promoting Tregs in mouse and human tumors, synergizing with anti-PD-1 therapy and reducing tumor growth through NK cell-dependent mechanisms. Targeting CCR8 may be an effective and safe strategy for antitumor immunotherapy.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Hematology

Overexpression of wild-type IL-7Rα promotes T-cell acute lymphoblastic leukemia/lymphoma

Ana Silva et al.

Summary: Overexpression of IL-7R alpha can promote T-cell tumorigenesis and lead to malignancies in various organs, involving activation of multiple signaling pathways and sensitivity to inhibitors of IL-7R-mediated signaling. Established tumors may no longer require high levels of IL-7R expression upon secondary transplantation, highlighting potential therapeutic implications.
Article Immunology

Patient-Derived Bone Marrow Spheroids Reveal Leukemia-Initiating Cells Supported by Mesenchymal Hypoxic Niches in Pediatric B-ALL

Juan Carlos Balandran et al.

Summary: B-ALL originates from malignant lymphoid precursors in the bone marrow that hijack the microenvironment niches. Patient-derived leukemia spheroids (PDLS) enriched with leukemia cells displaying stem cell features are supported by CXCL11(+) MSCs within hypoxic microenvironments, mimicking key features of tumor reemergence and initiation. This system provides a unique opportunity for personalized ex vivo avatars for B-ALL patients to evaluate their own LIC pathobiology and drug sensitivity in the context of the tumor microenvironment.

FRONTIERS IN IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Reduction of leukemic burden via bone-targeted nanoparticle delivery of an inhibitor of C-chemokine (C-C motif) ligand 3 (CCL3) signaling

Marian A. Ackun-Farmmer et al.

Summary: This study demonstrates the important role of CCL3 in regulating the bone marrow microenvironment in the context of leukemia, particularly in a murine model of bcCML. Inhibiting CCL3 signaling through CCR5 antagonism shows promise as a potential therapeutic strategy for restoring normal hematopoiesis and reducing leukemic burden within the BMME.

FASEB JOURNAL (2021)

Review Oncology

CCR4 as a Therapeutic Target for Cancer Immunotherapy

Osamu Yoshie

Summary: CCR4, a chemokine receptor mainly expressed by T cells, has been extensively studied for its selective expression on various T cell subsets and its role as a therapeutic target in cancer immunotherapy. The fully humanized and glyco-engineered monoclonal anti-CCR4 antibody Mogamulizumab has shown remarkable success in the treatment of refractory/relapsed ATLL and CTCLs. However, its efficient depletion of regulatory T cells can lead to severe adverse events, posing challenges in certain treatment settings. Studies on Mogamulizumab's application in advanced solid tumors are ongoing, highlighting its potential in expanding the clinical utility of CCR4 targeting therapies.

CANCERS (2021)

Review Oncology

CCR7 in Blood Cancers - Review of Its Pathophysiological Roles and the Potential as a Therapeutic Target

Carlos Cuesta-Mateos et al.

Summary: CCR7 is traditionally known as a chemokine receptor that aids in the homing of normal lymphocytes to secondary lymphoid tissues, but recent evidence suggests it plays a more diverse role beyond lymphatic spread of tumor cells. Evaluating CCR7 expression across blood cancers may reveal both classical and novel functions, with potential for novel therapeutic strategies to benefit patients with CCR7-positive hematopoietic tumors.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

CXCR4 allows T cell acute lymphoblastic leukemia to escape from JAK1/2 and BCL2 inhibition through CNS infiltration

Kirsti L. Walker et al.

Summary: Combination therapy with ruxolitinib and venetoclax shows promise for treating T-ALL, but additional inhibition of the CXCR4-CXCL12 axis may be needed to maximize the possibility of complete remission.

LEUKEMIA & LYMPHOMA (2021)

Article Biology

Biased action of the CXCR4-targeting drug plerixafor is essential for its superior hematopoietic stem cell mobilization

Astrid S. Jorgensen et al.

Summary: Plerixafor exhibits biased action by reversing the CXCL12 gradient across the bone marrow endothelium and showing superior therapeutic effect in HSC mobilization. In contrast, AMD11070, despite having superior antagonism, does not perform as effectively in HSC mobilization in vivo.

COMMUNICATIONS BIOLOGY (2021)

Article Genetics & Heredity

CARMA1 is required for Notch1-induced NF-κB activation in SIL-TAL1-negative T cell acute lymphoblastic leukemia

Ninghan Zhang et al.

Summary: The study demonstrates that CARMA1 is highly expressed in T-ALL cells and correlated with prognosis. Knockdown of CARMA1 only impacts the growth and proliferation of SIL-TAL1 fusion gene-negative T-ALL cells.

JOURNAL OF MOLECULAR MEDICINE-JMM (2021)

Article Biology

C-C chemokine receptor type 6 modulates the biological function of osteoblastogenesis by altering the expression levels of Osterix and OPG/RANKL

Lisha Li et al.

Summary: Inflammatory factors affect osteoblast and osteoclast activity in osteoporosis, and estrogen plays a role in bone metabolism through CCR6 signaling pathways. The study showed that CCR6 deletion reduced osteoblast activity and mineralization, while also influencing the expression of Osterix and RANKL, potentially regulating bone metabolism.

BIOSCIENCE TRENDS (2021)

Article Medicine, Research & Experimental

Nuclear PFKP promotes CXCR4-dependent infiltration by T cell acute lymphoblastic leukemia

Xueliang Gao et al.

Summary: PFKP, the major isoform of PFK1 in T-ALL, functions as a nucleocytoplasmic shuttling protein with nuclear export and localization sequences. Nuclear PFKP promotes the expression of CXCR4 to facilitate T-ALL cell invasion, which can be blocked with CXCR4 antagonists. The presence of nuclear PFKP in T cell malignancy correlates with poor survival and suggests its potential as a diagnostic marker.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Review Oncology

Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and Adults

Anand A. Patel et al.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2020)

Review Oncology

Targeting CXCR4 in AML and ALL

Daniel Cancilla et al.

FRONTIERS IN ONCOLOGY (2020)

Article Oncology

CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia

Carlo Cuesta-Mateos et al.

BIOMARKER RESEARCH (2020)

Review Chemistry, Medicinal

Advances of CCR5 antagonists: From small molecules to macromolecules

Baowen Qi et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Cell Biology

Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibition

Roger A. Habets et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

Article Biochemistry & Molecular Biology

Ectopic expression of CC chemokine receptor 7 promotes prostate cancer cells metastasis via Notch1 signaling

Ruoyang Du et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

Article Oncology

CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion

Xuanmao Jiao et al.

CANCER RESEARCH (2018)

Review Immunology

Chemokines and cancer: new immune checkpoints for cancer therapy

Nathan Karin

CURRENT OPINION IN IMMUNOLOGY (2018)

Article Biochemistry & Molecular Biology

Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies

Amnon Peled et al.

CYTOKINE (2018)

Article Biochemistry & Molecular Biology

A guide to chemokines and their receptors

Catherine E. Hughes et al.

FEBS JOURNAL (2018)

Article Medicine, Research & Experimental

Dual Targeting of Acute Leukemia and Supporting Niche by CXCR4-Directed Theranostics

Stefan Habringer et al.

THERANOSTICS (2018)

Article Immunology

92R Monoclonal Antibody Inhibits Human CCR9+ Leukemia Cells Growth in NSG Mice Xenografts

Beatriz Somovilla-Crespo et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Biochemistry & Molecular Biology

Intrathymic Notch3 and CXCR4 combinatorial interplay facilitates T-cell leukemia propagation

Francesca Ferrandino et al.

ONCOGENE (2018)

Review Immunology

The Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment

Katharina Helene Susek et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Biochemistry & Molecular Biology

Pathological roles of the homeostatic chemokine CXCL12

Rik Janssens et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2018)

Article Biochemical Research Methods

Chemokine receptor - Directed imaging and therapy

Andreas K. Buck et al.

METHODS (2017)

Editorial Material Oncology

Molecular regulation of T-ALL cell infiltration into the CNS

Judy L. Cannon et al.

ONCOTARGET (2017)

Review Medicine, General & Internal

Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside

Byung-Sik Cho et al.

KOREAN JOURNAL OF INTERNAL MEDICINE (2017)

Review Immunology

Chemokines and Chemokine Receptors in Lymphoid Tissue Dynamics

Olga Schulz et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)

Article Biochemistry & Molecular Biology

CCL25/CCR9 Signal Promotes Migration and Invasion in Hepatocellular and Breast Cancer Cell Lines

Ziqi Zhang et al.

DNA AND CELL BIOLOGY (2016)

Article Cell Biology

Role of CXCR4-mediated bone marrow colonization in CNS infiltration by T cell acute lymphoblastic leukemia

Tanja Rezzonico Jost et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2016)

Article Multidisciplinary Sciences

Endogenous dendritic cells from the tumor microenvironment support T-ALL growth via IGF1R activation

Todd A. Triplett et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Review Immunology

Human RAG mutations: biochemistry and clinical implications

Luigi D. Notarangelo et al.

NATURE REVIEWS IMMUNOLOGY (2016)

Article Oncology

Notch1-induced T cell leukemia can be potentiated by microenvironmental cues in the spleen

Shihui Ma et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)

Review Biochemistry & Molecular Biology

Hematopoietic stem cell niche maintenance during homeostasis and regeneration

Avital Mendelson et al.

NATURE MEDICINE (2014)

Letter Pharmacology & Pharmacy

Targeting CCR4 as an emerging strategy for cancer therapy and vaccines

Jagadeesh Bayry et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2014)

Article Multidisciplinary Sciences

Epigenetic Inactivation of Notch-Hes Pathway in Human B-Cell Acute Lymphoblastic Leukemia

Shao-Qing Kuang et al.

PLOS ONE (2013)

Article Multidisciplinary Sciences

Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans

Daisuke Sugiyama et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Oncology

CCR5 Antagonist Blocks Metastasis of Basal Breast Cancer Cells

Marco Velasco-Velazquez et al.

CANCER RESEARCH (2012)

Article Immunology

Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia

Keunwook Lee et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2012)

Review Cell Biology

CXCR3 ligands: redundant, collaborative and antagonistic functions

Joanna R. Groom et al.

IMMUNOLOGY AND CELL BIOLOGY (2011)

Article Cell & Tissue Engineering

Distinct Hematopoietic Stem Cell Subtypes Are Differentially Regulated by TGF-β1

Grant A. Challen et al.

CELL STEM CELL (2010)

Article Oncology

CXCL12 (SDF-1)/CXCR4 Pathway in Cancer

Beverly A. Teicher et al.

CLINICAL CANCER RESEARCH (2010)

Review Pharmacology & Pharmacy

Therapeutic targeting of microenvironmental interactions in leukemia: Mechanisms and approaches

Marina Konopleva et al.

DRUG RESISTANCE UPDATES (2009)

Article Multidisciplinary Sciences

CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia

Silvia Buonamici et al.

NATURE (2009)

Article Multidisciplinary Sciences

Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment

Olaia Naveiras et al.

NATURE (2009)

Review Medicine, General & Internal

An insight into molecular mechanisms of human T helper cell differentiation

Kirsi J. Rautajoki et al.

ANNALS OF MEDICINE (2008)

Article Cell & Tissue Engineering

N-cadherin expression level distinguishes reserved versus primed states of hematopoietic stem cells

Jeffrey S. Haug et al.

CELL STEM CELL (2008)

Article Developmental Biology

Retinoic acid and Cyp26b1 are critical regulators of osteogenesis in the axial skeleton

Kirsten M. Spoorendonk et al.

DEVELOPMENT (2008)

Article Multidisciplinary Sciences

Haematopoietic stem cell release is regulated by circadian oscillations

Simon Mendez-Ferrer et al.

NATURE (2008)

Article Multidisciplinary Sciences

In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination

Jagadeesh Bayry et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Biochemistry & Molecular Biology

Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment

Benedetto Sacchetti et al.

Article Multidisciplinary Sciences

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

Antoine E. Karnoub et al.

NATURE (2007)

Article Biochemistry & Molecular Biology

Targeting the NF-kappa B signaling pathway in Notch1-induced T-cell leukemia

Tomas Vilimas et al.

NATURE MEDICINE (2007)

Review Immunology

Sonic hedgehog signalling in T-cell development and activation

Tessa Crompton et al.

NATURE REVIEWS IMMUNOLOGY (2007)

Article Immunology

Phenotypic plasticity of T cell progenitors upon exposure to Notch ligands

Andreas Krueger et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2006)

Article Biochemistry & Molecular Biology

Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells

Orit Kollet et al.

NATURE MEDICINE (2006)

Review Medicine, Research & Experimental

The stem cell niches in bone

T Yin et al.

JOURNAL OF CLINICAL INVESTIGATION (2006)

Article Multidisciplinary Sciences

Osteoblastic cells regulate the haematopoietic stem cell niche

LM Calvi et al.

NATURE (2003)

Article Multidisciplinary Sciences

Wnt proteins are lipid-modified and can act as stem cell growth factors

K Willert et al.

NATURE (2003)

Article Multidisciplinary Sciences

Combined expression of pTα and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis

D Bellavia et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)